1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Earnings

Stada Grows Twice As Fast As CHC Market In 2023

 
• By Tom Gallen

Stada's local brand focus helped it deliver Consumer Healthcare sales growth of 16% in 2023 ensuring the German firm significantly outpaced the overall market growth rate of 7%.

Stada_HQ
• Source: Stada

Stada’s Consumer Healthcare business grew more than twice as fast as the global OTC market in 2023 as sales increased across all regions.

The Bad Vilbel, Germany-based firm reported CHC sales up 16% to €1.49bn ($1.62bn) over the 12 months, outpacing a non-prescription...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

BioGaia Takes Probiotics To Netherlands For First Time

 
• By Tom Gallen

Adopting an online approach, BioGaia is set to enter the Dutch market for probiotic dietary supplements. The firm announced the move as it reported lower sales in Q1.

IQVIA Consumer Health: Digestive Category Driving Global OTC Market Growth

 
• By David Ridley

An increasing awareness of and interest in gut health helped the global OTC market grow by 4.6% in value terms in 2024, according to IQVIA Consumer Health.

Dermapharm Seeks To Put Stop To Spanish Slide

 
• By Tom Gallen

Dermapharm shakes up management of Arkopharma subsidiary in Spain with turnaround plan not showing results.

C&D Divesting Flawless, Spinbrush Lines, Says Gummy Vitamin Brands Might Not Stick

 
• By Malcolm Spicer

C&D reports Q1 net sales dropped 2.4% to $1.48bn, below its guidance for around 1% growth. Its brands’ sales at retail and market share grew in the quarter, but “experienced slowing category growth in the US market” as retailers reduced inventory levels.

More from Business